|
|
|||||||||
Clinical Investigations |
1 Department of Nuclear Medicine, University Hospital, Aachen University of Technology, Aachen, Germany
2 Department of Internal Medicine I (Cardiology), University Hospital, Aachen University of Technology, Aachen, Germany
Myocardial perfusion imaging with 99mTc-tetrofosmin is based on the assumption of a linear correlation between myocardial blood flow (MBF) and tracer uptake. However, it is known that 99mTc-tetrofosmin uptake is directly related to energy-dependent transport processes, such as Na+/H+ ion channel activity, as well as cellular and mitochondrial membrane potentials. Therefore, cellular alterations that affect these energy-dependent transport processes ought to influence 99mTc-tetrofosmin uptake independently of blood flow. Because metabolism (18F-FDG)-perfusion (99mTc-tetrofosmin) mismatch myocardium (MPMM) reflects impaired but viable myocardium showing cellular alterations, MPMM was chosen to quantify the blood flow-independent effect of cellular alterations on 99mTc-tetrofosmin uptake. Therefore, we compared microsphere-equivalent MBF (MBF_micr; 15O-water PET) and 99mTc-tetrofosmin uptake in MPMM and in "normal" myocardium. Methods: Forty-two patients with severe coronary artery disease, referred for myocardial viability diagnostics, were examined using 18F-FDG PET and 99mTc-tetrofosmin perfusion SPECT. Relative 18F-FDG and 99mTc-tetrofosmin uptake values were calculated using 18 segments per patient. Normal myocardium and MPMM myocardium were classified using a previously validated 99mTc-tetrofosmin SPECT/18F-FDG PET score. In addition, 15O-water PET was performed to assess kinetic-modeled MBF (MBF_kin), the water-perfusable tissue fraction (PTF), and the resulting MBF_micr (MBF_kin·PTF), which is comparable to tracer uptake values. 99mTc-tetrofosmin uptake and MBF_micr values were calculated for all normal and MPMM segments and averaged within their respective classifications. Results: Mean relative 99mTc-tetrofosmin uptake was 86% ± 1% in normal myocardium and 56% ± 1% in MPMM, showing a significant difference (P < 0.001), as was expected from the classification. Contrary to these findings, mean MBF_micr in MPMM myocardium was 0.60 ± 0.03 mL·min-1·mL-1, which did not significantly differ from normal myocardium (0.64 ± 0.01 mL·min-1·mL-1). All values are given as mean ± SEM. Conclusion: Differences between reduced 99mTc-tetrofosmin uptake and the unchanged MBF_micr in MPMM myocardium suggest that the pathophysiologic basis of MPMM is not a blood flow reduction but cellular alterations that affect uptake and retention of 99mTc-tetrofosmin independently of blood flow. Therefore, it seems that perfusion deficits in MPMM myocardium are greatly overestimated by 99mTc-tetrofosmin and that it tends to give false-positive findings.
Key Words: metabolism-perfusion mismatch 99mTc-tetrofosmin 18F-FDG myocardial blood flow 15O-water
This article has been cited by other articles:
![]() |
H. Iida, T. Hayashi, S. Eberl, and H. Saji Quantification in SPECT Cardiac Imaging J. Nucl. Med., January 1, 2003; 44(1): 40 - 42. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |